Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities

Author:

Rusconi S1,Moonis M1,Merrill D P1,Pallai P V1,Neidhardt E A1,Singh S K1,Willis K J1,Osburne M S1,Profy A T1,Jenson J C1,Hirsch M S1

Affiliation:

1. Infectious Disease Unit, Massachusetts General Hospital, Boston 02114, USA.

Abstract

PIC 024-4 and PRO 2000 are naphthalene sulfonate polymers that bind to CD4 with nanomolar affinity and block binding of gp120. Both have activity against human immunodeficiency virus type 1 in H9 cells, peripheral blood mononuclear cells, and primary monocyte/macrophages, are synergistic with zidovudine, and do not inhibit tetanus toxoid-stimulated T-cell proliferation at anti-human immunodeficiency virus type 1 concentrations.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference23 articles.

1. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice;Arulanandam A. R. N.;J. Exp. Med.,1993

2. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions;Callahan L. N.;J. Virol.,1991

3. Chou J. H. and T.-C. Chou. 1989. Dose-effect analysis with microcomputers: quantitation of ED50 LD50 synergism antagonism low-dose risk receptor-ligand binding and enzyme kinetics: a computer software for IBM-PC and manual. Biosoft Cambridge Mass.

4. Chou T.-C. 1991. The median-effect principle and the combination index for quantitation of synergism and antagonism p. 61-102. In T.-C. Chou and D. C. Rideout (ed.) Synergism and antagonism in chemotherapy. Academic Press New York.

5. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors;Chou T.;Adv. Enzyme. Regul.,1984

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3